logo

For the Inventor, By the Inventor

Ballerup, Denmark

Mogens Larsen

This inventor holds 5 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignee: Leo-Pharma A/s. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mogens Larsen. Retrieved from https://idiyas.com/inventor/mogens-larsen-8rkreuo2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 60.0

 

Average Co-Inventor Count = 4.9

ph-index = 1


Location History:

  • Ballerup, GB (2020)
  • Ballerup, DK (2020 - 2024)

Company Filing History:

goldMedal5 out of 67 
 
Leo-Pharma A/s
 patents

Years Active: 2020-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 12065429 - Small molecule modulators of IL-17 (2024-08-20),
2. 11377425 - Small molecule modulators of IL-17 (2022-07-05),
3. 10851116 - Bicyclic amines as novel JAK kinase inhibitors (2020-12-01),
4. 10799507 - 5-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2.5]octane-8-carboxylic acid derivatives as novel JAK kinase inhibitors (2020-10-13),
5. 10703751 - Amino-imidazopyridine derivatives as Janus kinase inhibitors and pharmaceutical use thereof (2020-07-07),

Title: The Innovations of Mogens Larsen

Introduction

Mogens Larsen is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of small molecule modulators. With a total of five patents to his name, Larsen's work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

Larsen's latest patents focus on small molecule modulators of IL-17. The present invention relates to a compound according to formula (I) and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, such as dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.

Career Highlights

Mogens Larsen is currently employed at Leo-Pharma A/S, a company renowned for its commitment to dermatological research and development. His work at Leo-Pharma has allowed him to focus on innovative solutions that address pressing medical needs.

Collaborations

Larsen collaborates with talented professionals in his field, including colleagues Andreas Ritzen and Mark Andrews. Their combined expertise fosters a productive environment for innovation and research.

Conclusion

Mogens Larsen's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…